Yang Chun-Hua, Chen Xue-Xia, Chen Li, Zheng Dong-Hua, Liu Qiong-Shan, Xie Wen-Feng, Zhou Tian-Biao, Drummen Gregor P C
Department of Emergency, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Department of Critical Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Pediatr Transplant. 2017 Nov;21(7). doi: 10.1111/petr.12920. Epub 2017 Apr 27.
Results on the relationship between CTLA4 -318C/T (rs5742909) gene polymorphism and risk of acute rejection in renal transplantation are still conflicting. This meta-analysis was performed to update the association between CTLA4 -318C/T and risk of acute rejection in renal transplantation. The association investigations were identified from PubMed and Cochrane Library, and eligible studies were included and synthesized using meta-analysis method. Twelve reports were included in this meta-analysis for the association of CTLA4 -318C/T gene polymorphism with acute rejection risk in renal transplantation, consisting of 728 acute rejection patients and 1628 non-acute rejection controls. The association between CTLA4 -318C/T gene polymorphism and acute rejection risk in renal transplantation for overall populations was not found in this meta-analysis (T allele: OR=0.96, 95% CI: 0.60-1.54, P=.88; TT genotype: OR=0.90, 95% CI: 0.47-1.71, P=.74; CC genotype: OR=1.00, 95% CI: 0.62-1.59, P=.98). Interestingly, T allele was associated with the risk of acute rejection in renal transplantation in African population. In conclusion, CTLA4 -318C/T gene polymorphism is not associated with the risk of acute rejection in renal transplantation in overall populations.
关于细胞毒性T淋巴细胞相关抗原4(CTLA4)-318C/T(rs5742909)基因多态性与肾移植急性排斥反应风险之间的关系,研究结果仍存在争议。进行这项荟萃分析是为了更新CTLA4 -318C/T与肾移植急性排斥反应风险之间的关联。通过PubMed和Cochrane图书馆检索相关关联研究,并纳入符合条件的研究,采用荟萃分析方法进行综合分析。本荟萃分析纳入了12篇关于CTLA4 -318C/T基因多态性与肾移植急性排斥反应风险关联的报告,包括728例急性排斥反应患者和1628例非急性排斥反应对照。本荟萃分析未发现CTLA4 -318C/T基因多态性与总体人群肾移植急性排斥反应风险之间存在关联(T等位基因:优势比[OR]=0.96,95%置信区间[CI]:0.60 - 1.54,P = 0.88;TT基因型:OR = 0.90,95% CI:0.47 - 1.71,P = 0.74;CC基因型:OR = 1.00,95% CI:0.62 - 1.59,P = 0.98)。有趣的是,在非洲人群中,T等位基因与肾移植急性排斥反应风险相关。总之,CTLA4 -318C/T基因多态性与总体人群肾移植急性排斥反应风险无关。